The successful delivery of the BACE 1 antisense gene and tau‐related fibril inhibitor peptide by nanoparticle (NP) carriers resulted in a notable decrease in BACE positive signals and a reduction in p‐tau positive signals in mice with AD. Here, MAPT is linked to Alzheimer disease.